Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Pseudaulacaspis prunicola

ABSTRACT: Pseudaulacaspis prunicola Genome sequencing and assembly

PROVIDER: PRJNA863380 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR20709320_1.fastq.gz	Fastqsanger.gz
	SRR20709320_2.fastq.gz	Fastqsanger.gz
	SRR20709321_1.fastq.gz	Fastqsanger.gz
	SRR20709321_2.fastq.gz	Fastqsanger.gz
	SRR20709322_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

Xanthomonas prunicola

Project description:Xanthomonas prunicola overview

| PRJNA821307 | ENA

Aplosporella prunicola

Project description:Aplosporella prunicola overview

| PRJNA203340 | ENA

Aplosporella prunicola CBS 121167

Project description:Aplosporella prunicola CBS 121167 Genome sequencing and assembly

| PRJNA196034 | ENA

Xanthomonas prunicola strain:CFBP8354 | isolate:IVIA 3287.2

Project description:Xanthomonas prunicola CFBP8354 Genome sequencing and assembly

| PRJNA418711 | ENA

Xanthomonas prunicola strain:CFBP8353 | isolate:IVIA 3287.1

Project description:Xanthomonas prunicola CFBP8353 Genome sequencing and assembly

| PRJNA418695 | ENA

Xanthomonas prunicola strain:Arg-1 | isolate:Arg-1

Project description:Xanthomonas prunicola strain:Arg-1 | isolate:Arg-1 Genome sequencing and assembly

| PRJNA819403 | ENA

Aplosporella prunicola CBS 121167 isolate:CBS 121167

Project description:Aplosporella prunicola CBS 121167 transcriptome

| PRJNA459547 | ENA

Xanthomonas

Project description:Xanthomonas prunicola CFBP8355 Genome sequencing and assembly

| PRJNA418723 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Coniochaeta

Project description:Genome sequencing and assembly of Coniochaeta spp., C. endophytica, C. prunicola

| PRJNA526083 | ENA